An open-label, randomized controlled trial of sulfamethoxazole-trimethoprim for Pneumocystis prophylaxis: results of 52-week follow-up.
Masako UtsunomiyaHiroaki DobashiToshio OdaniKazuyoshi SaitoNaoto YokogawaKenji NagasakaKenchi TakenakaMakoto SoejimaTakahiko SugiharaHiroyuki HagiyamaShinya HirataKazuo MatsuiYoshinori NonomuraMasahiro KondoFumihito SuzukiYasushi NawataMakoto TomitaMari KiharaWaka Yokoyama-KokuryoFumio HiranoHayato YamazakiRyoko SakaiToshihiro NankiRyuji KoikeNobuyuki MiyasakaMasayoshi HarigaiPublished in: Rheumatology advances in practice (2020)
University Hospital Medical Information Network Clinical Trials Registry, UMIN000007727.